Medical utilisation and cost outcomes of sleep apnoea

W. De Backer (Antwerp, Belgium)

Source: ERS Conference
Number: 7

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. De Backer (Antwerp, Belgium). Medical utilisation and cost outcomes of sleep apnoea. ERS Conference

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Health impact of snoring and sleep apnoea in the community in Singapore
Source: Eur Respir J 2001; 18: Suppl. 33, 439s
Year: 2001

Prevalence of excessive daytime sleepiness and obstructive sleep apnea risk in a large line of primary health care users
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Sleep quality and functional outcomes in sleep apnea patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Clinical characteristics and outcomes of patients with obstructive sleep apnea requiring intensive care
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008

Public health and medicolegal implications of sleep apnoea.
Source: Eur Respir J 2003; 21: 561
Year: 2003


Public health and medicolegal implications of sleep apnoea
Source: Guideline 2002
Year: 2002

Public health and medicolegal implications of sleep apnoea
Source: Eur Respir J 2002; 20: 1594-1609
Year: 2002


Correlation between excessive daytime sleepiness and the risk for obstructive sleep apnea with academic performance among medical students at UP-PGH
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011


Impact of cardiorespiratory sleep staging for home sleep apnea testing
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020


Awareness and knowledge of obstructive sleep apnea in the general population
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016


New organisation for follow-up and assessment of treatment efficacy in sleep apnoea
Source: Eur Respir Rev, 28 (153) 190059; 10.1183/16000617.0059-2019
Year: 2019



Elevated healthcare utilisation in young adult males with obstructive sleep apnoea
Source: Eur Respir J 2008; 31: 273-279
Year: 2008



Comorbidity and healthcare costs in patients with obstructive sleep apnoea
Source: Breathe 2011; 8: 95-104
Year: 2011

Prevalence of sleep apnoea and its associated impact on quality of life in a primary care COPD population
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Impact of excessive sleepiness associated with obstructive sleep apnea on work productivity in the United States
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019


The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016


Surgery for obstructive sleep apnea: Sleep endoscopy determinants of outcome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012

An integrated model involving sleep units and primary care for the diagnosis of sleep apnoea
Source: Eur Respir J 2013; 42: 1151-1154
Year: 2013


Health related quality of life in hypertension and concomitant obstructive sleep apnoea: a community-based study
Source: Eur Respir J 2004; 24: Suppl. 48, 329s
Year: 2004